Matthias Ruebner

8PUBLICATIONS
204CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Gene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 04, 2026
Clinical Relevance of Post-Treatment Circulating Tumor DNA Detection in Early Breast Cancer Using a Tissue-Free Epigenomic Assay: A 2-Year Landmark Analysis.

|May 13, 2025
Large B-cell lymphoma imprints a dysfunctional immune phenotype that persists years after treatment.

Richard J Pelzl, Giulia Benintende, Franziska Gsottberger

|May 02, 2025
A Digital Home-Based Health Care Center for Remote Monitoring of Side Effects During Breast Cancer Therapy: Prospective, Single-Arm, Monocentric Feasibility Study.

Hanna Huebner, Lena A Wurmthaler, Chloë Goossens

|Jun 05, 2024
Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma.

Flurina A M Saner, Kazuaki Takahashi, Timothy Budden

|Oct 12, 2022
Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes.

Nicola S Meagher, Kylie L Gorringe, Matthew Wakefield

|Sep 29, 2020
PIWI-Like 1 and PIWI-Like 2 Expression in Breast Cancer.

Ramona Erber, Julia Meyer, Helge Taubert

Pageof 2

Frequent Collaborators

5 joint publications

Peter A Fasching

3 joint publications

Ramona Erber

3 joint publications

Matthias W Beckmann

2 joint publications

Nicola S Meagher